Eli Lilly and Co

LLY

Company Profile

  • Business description

    Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

  • Contact

    Lilly Corporate Center
    IndianapolisIN46285
    USA

    T: +1 317 276-2000

    E: [email protected]

    https://www.lilly.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    47,000

Eli Lilly and Co News & Analysis

stocks

Eli Lilly earnings: Weak Orforglipron obesity data weighs down a strong quarter

With today’s share drop, we think Lilly stock looks fairly valued.
markets

June 2025 US stock market outlook: Has the storm passed?

Be wary of the recent complacency; there’s turbulent water ahead before the skies clear.
markets

US stock market outlook: Where we see opportunities in Q2

A bear market in AI stocks leads to more attractive valuations.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,317.2026.50-0.28%
CAC 408,225.630.15-0.00%
DAX 4024,239.8932.100.13%
Dow JONES (US)47,238.57503.961.08%
FTSE 1009,645.6267.050.70%
HKSE26,160.15192.170.74%
NASDAQ23,231.47289.671.26%
Nikkei 22549,299.65658.041.35%
NZX 50 Index13,391.5914.490.11%
S&P 5006,797.8359.390.88%
S&P/ASX 2009,019.0025.20-0.28%
SSE Composite Index3,950.3127.900.71%

Market Movers